Zogenix to Release Second Quarter 2016 Financial Results and Host Conference Call and Webcast on August 9

EMERYVILLE, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. ZGNX, a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that it will report its financial results for the second quarter ended June 30, 2016 after the market close, and will host a corporate update conference call and webcast on Tuesday, August 9^th, at 4:30 PM Eastern Time.

About Zogenix
Zogenix, Inc. ZGNX is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

For more information, visit www.zogenix.com.